Compound details
Quinquenoside F1
| Compound ID | CDAMM02850 |
|---|---|
| Common name | Quinquenoside F1 | IUPAC name | 2-[4,5-dihydroxy-6-(hydroxymethyl)-2-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-(2,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
| Molecular formula | C42H74O15 |
| Retention time | 20.81 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 841.485 | Theoretical mz | 841.492 |
| Error | 7.98 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4355 |
| Inchi key | UGMWBGKFEUXCMG-UHFFFAOYNA-N |
|---|---|
| Smiles | OCC1OC(OC2C(O)C(O)C(OC2OC3CCC4(C)C(CCC5(C)C4CC(O)C6C(CCC65C)C(O)(C)CCC(O)C(O)(C)C)C3(C)C)CO)C(O)C(O)C1O |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SwissTargetPrediction and SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SwissTargetPrediction and SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SwissTargetPrediction and SEA |
| Q9Y251 | HPSE | Heparanase | T47623 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T47623 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | Q9Y251 | HPSE |
| T47623 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q9Y251 | HPSE |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |